publication venue for
- 3,3'-Diindolylmethane improves pathology and neurological outcome following traumatic brain injury.. 22:-. 2025
- Corrigendum to "A real-time neurophysiologic stress test for the aging brain: Novel perioperative and ICU applications of EEG in older surgical patients" Neurotherapeutics 20 (4) (2023) 975-1000.. 21:-. 2024
- A Real-Time Neurophysiologic Stress Test for the Aging Brain: Novel Perioperative and ICU Applications of EEG in Older Surgical Patients.. 20:975-1000. 2023
- Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers.. 19:209-227. 2022
- Genetic Variation and Response to Neurocritical Illness: a Powerful Approach to Identify Novel Pathophysiological Mechanisms and Therapeutic Targets.. 17:581-592. 2020
- Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned.. 17:1393-1405. 2020
- Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials.. 14:62-68. 2017
- Urate as a Marker of Risk and Progression of Neurodegenerative Disease.. 14:148-153. 2017
- A systems approach to drug discovery in Alzheimer's disease.. 12:126-31. 2015
- Stuck in the mire.. 12:1-2. 2015
- Synaptic therapy in Alzheimer's disease: a CREB-centric approach.. 12:29-41. 2015
- Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?. 11:34-46. 2014
- Vascular cognitive impairment: disease mechanisms and therapeutic implications.. 8:361-73. 2011
- Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's disease.. 6:141-51. 2009
- Brain mapping as a tool to study neurodegeneration.. 4:387-400. 2007